share_log

GE HealthCare Technologies Repeat Insider Selling Not A Positive Indicator

GE HealthCare Technologies Repeat Insider Selling Not A Positive Indicator

通用电气医疗科技重复内幕抛售不是一个积极的指标
Simply Wall St ·  03/15 09:33

A number of GE HealthCare Technologies Inc. (NASDAQ:GEHC) insiders sold their shares in the last year, which may have raised concerns among investors. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

去年,通用电气医疗科技公司(纳斯达克股票代码:GEHC)的许多内部人士出售了股票,这可能引起了投资者的担忧。在评估内幕交易时,了解内部人士是买入还是卖出通常更有利,因为后者可能有多种解释。但是,当多个内部人士在特定期限内出售股票时,股东应注意,因为这可能是一个危险信号。

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

尽管我们认为股东不应干脆关注内幕交易,但我们认为完全忽视内幕交易是愚蠢的。

The Last 12 Months Of Insider Transactions At GE HealthCare Technologies

通用电气医疗科技公司过去 12 个月的内幕交易

The CEO of Ultrasound, Roland Rott, made the biggest insider sale in the last 12 months. That single transaction was for US$191k worth of shares at a price of US$77.37 each. So it's clear an insider wanted to take some cash off the table, even below the current price of US$88.33. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was 97% of Roland Rott's holding.

超声波首席执行官罗兰·罗特进行了过去12个月中最大规模的内幕交易。这笔单笔交易是价值19.1万美元的股票,每股价格为77.37美元。因此,很明显,一位内部人士想从桌上提取一些现金,甚至低于目前的88.33美元。如果内部人士一直在卖出,特别是如果他们卖出低于当前价格,我们通常认为这是负面的,因为这意味着他们认为较低的价格是合理的。但是,请注意,卖家可能有各种各样的卖出原因,因此我们不确定他们对股价的看法。我们注意到,最大的单笔销售是罗兰·罗特持有的97%。

In the last year GE HealthCare Technologies insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

去年,通用电气医疗科技内部人士没有购买任何公司股票。下图显示了去年的内幕交易(公司和个人)。如果你点击图表,你可以看到所有的个人交易,包括股价、个人和日期!

insider-trading-volume
NasdaqGS:GEHC Insider Trading Volume March 15th 2024
纳斯达克股票代码:GEHC 内幕交易量 2024 年 3 月 15 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一样,那么你不会想错过这份业内人士正在收购的成长型公司的免费名单。

Insider Ownership Of GE HealthCare Technologies

通用电气医疗科技的内部所有权

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. GE HealthCare Technologies insiders own about US$25m worth of shares. That equates to 0.06% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

测试公司领导者与其他股东之间一致性的另一种方法是查看他们拥有多少股份。较高的内部所有权通常会使公司领导层更加关注股东的利益。通用电气医疗科技内部人士拥有价值约2500万美元的股票。这相当于该公司的0.06%。这种内部所有权水平不错,但还没有特别突出。这无疑表明了一定程度的一致性。

So What Does This Data Suggest About GE HealthCare Technologies Insiders?

那么,这些数据对通用电气医疗科技内部人士有何启示呢?

There haven't been any insider transactions in the last three months -- that doesn't mean much. Still, the insider transactions at GE HealthCare Technologies in the last 12 months are not very heartening. But we do like the fact that insiders own a fair chunk of the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. You'd be interested to know, that we found 2 warning signs for GE HealthCare Technologies and we suggest you have a look.

在过去的三个月中,没有任何内幕交易——这并不意味着什么。尽管如此,GE Healthcare Technologies在过去12个月中的内幕交易并不十分令人鼓舞。但是我们确实喜欢内部人士拥有公司相当一部分股份的事实。虽然我们喜欢了解内部人士的所有权和交易情况,但在做出任何投资决策之前,我们一定要考虑股票面临的风险。你可能会有兴趣知道,我们发现了GE Healthcare Technologies的两个警告信号,我们建议你看看。

Of course GE HealthCare Technologies may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,通用电气医疗科技可能不是最值得购买的股票。因此,您可能希望看到这个免费的高质量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发